Equitable Trust Co. Has $75.94 Million Holdings in HCA Healthcare, Inc. $HCA

Equitable Trust Co. lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 1.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 160,475 shares of the company’s stock after buying an additional 2,036 shares during the quarter. HCA Healthcare makes up about 3.5% of Equitable Trust Co.’s portfolio, making the stock its 3rd biggest position. Equitable Trust Co. owned 0.07% of HCA Healthcare worth $75,943,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Norges Bank purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at $1,262,513,000. Life Cycle Investment Partners Ltd bought a new stake in HCA Healthcare during the 4th quarter valued at about $374,037,000. Viking Global Investors LP grew its stake in HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in shares of HCA Healthcare by 4,545.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after acquiring an additional 649,058 shares in the last quarter. Finally, Danske Bank A S bought a new position in HCA Healthcare in the third quarter worth approximately $115,530,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Truist Financial set a $413.00 price target on HCA Healthcare in a research report on Thursday, June 4th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a report on Tuesday, April 28th. Weiss Ratings lowered shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Royal Bank Of Canada cut their price objective on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Finally, Leerink Partners lowered their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $497.14.

HCA Healthcare Trading Down 0.4%

Shares of HCA opened at $408.77 on Friday. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The stock has a fifty day moving average price of $398.13 and a 200-day moving average price of $460.77. The firm has a market cap of $90.68 billion, a PE ratio of 14.06, a P/E/G ratio of 1.30 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period in the prior year, the company earned $6.45 earnings per share. The company’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th were paid a dividend of $0.78 per share. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s coverage remained constructive overall, with analysts assigning the stock an average “Moderate Buy” rating, suggesting Wall Street still sees upside potential. HCA Healthcare, Inc. (NYSE:HCA) Receives Average Rating of “Moderate Buy” from Analysts
• Positive Sentiment: One commentary piece argued the recent pullback should not be seen as a fundamental breakdown, citing improving revenue, profitability, and ongoing buybacks as reasons the stock may be undervalued. HCA Healthcare’s Fall Shouldn’t Be Construed As Failing Health
• Neutral Sentiment: HCA-affiliated hospitals announced operational updates, including LewisGale Regional Health System opening a simulation center and TriStar Greenview Regional Hospital naming a new COO. These are positive for operations, but likely not major stock catalysts. LewisGale Regional Health System unveils new realistic simulation center TriStar Greenview Regional Hospital selects new Chief Operating Officer
• Neutral Sentiment: HCA’s Mission Health dropped its BSN requirement for nurses in North Carolina, a workforce-policy change that may help staffing flexibility but is unlikely to move the stock by itself. HCA’s Mission Health drops BSN requirement for nurses in North Carolina
• Negative Sentiment: Barclays reaffirmed its “equal weight” rating but cut its price target sharply to $427 from $496, which can weigh on sentiment even though the new target still implies some upside from current levels. Analyst rating update
• Negative Sentiment: A separate analyst-focused report highlighted a downgrade, reinforcing the view that some Wall Street firms are becoming less bullish on HCA after earnings. This HCA Healthcare Analyst Is No Longer Bullish
• Negative Sentiment: Post-earnings coverage questioned whether HCA should be bought, sold, or held, reflecting investor uncertainty after the latest quarterly results and contributing to cautious trading. HCA Healthcare (HCA): Buy, sell, or hold post Q1 earnings?

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.